IQuity Lands NIH Grant To Help Identify Alzheimer's Early

 
• By Reed Miller

The $320k grant will support research that builds on IQuity’s autoimmune diagnostic expertise and new data analytics platform. The company believes the emerging therapies for Alzheimer's will be most effective if they are used to treat the disease early in its progression.

MT1810_Synapse_1050113234_1200.jpg
A rendering of synapse destruction in neurodegenerative disease • Source: shutterstock.com

IQuity Labs Inc.'s plan to apply its new machine learning-based data mining and analytics platform to the early detection of Alzheimer's disease has earned the endorsement of the US National Institutes of Health. In September, NIH's National Institute on Aging (NIA) awarded the company a $320,000 supplemental grant to help get the project going.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D